MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Rare causes of Opsoclonus Myoclonus Ataxia Syndrome

    A. Venkitachalam, N. Chaudhary (Mumbai, India)

    Objective: To evaluate for rare causes of Opsoclonus Myoclonus Ataxia Syndrome. Background: Opsoclonus Myoclonus is a rare acute onset neurological disorder characterized by associated ocular,…
  • 2019 International Congress

    Benefit and Weakness with botulinum toxin: time course and relationship.

    P. Kassavetis, K. Alter, C. Lungu, B. Karp (Bathesda, MD, USA)

    Objective: To compare the timecourse of and relationship between benefit and weakness after botulinum toxin (BoNT) injection. Background: The timecourse of benefit onset and duration…
  • 2019 International Congress

    Somatization disorder (SD) and Parkinson’s Disease (PD) in Mexican population

    M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Polo-Morales, A. Alcocer-Salas (Ciudad de México, Mexico)

    Objective: Identify, in Mexican patients with PD, the prevalence of SD as well as its impact on cognitive and motor impairment. Background: SD refers to…
  • 2019 International Congress

    Differences in correlation with cardiac sympathetic denervation between depression and anhedonia in drug naïve Parkinson disease patients

    H. Murakami, T. Shiraishi, T. Umehara, S. Omoto, H. Motegi, R. Nakada, T. Sato, A. Onda, H. Matsuno, T. Komatsu, K. Bono, K. Sakai, H. Mitsumura, Y. Iguchi (Tokyo, Japan)

    Objective: To compare the correlation with some assessments of DAT scan and myocardial MIBG scintigraphy between depression and anhedonia in drug naive Parkinson's Disease (PD)…
  • 2019 International Congress

    Can a smartphone accelerometer differentiate between functional and organic tremor ?

    M. Khider Ahmed, T. Mouton, J. Ackerman, N. Brey, C. Albertyn, F. Henning, J. Carr (Cape Town, South Africa)

    Objective: The aim of the study was to determine if a smartphone accelerometer can distinguish functional tremor from organic tremor. Background: Differentiating functional tremor from…
  • 2019 International Congress

    Modern aspects of genetics of child cerebral palsy with symptomatic epilepsy

    D. Aminova (Tashkent, Uzbekistan)

    Objective: Objective of the study was the molecular genetic aspects of child cerebral palsy and symptomatic epilepsy in children. Background: From a genetic point of…
  • 2019 International Congress

    Using whole genome sequencing and intronic sequence analysis to identify pathogenic variants in Parkin-related Parkinson’s Disease

    R. Davis, K. Kumar, F. Edema-Hildebrand, J-S. Park, B. Koentjoro, V. Gayevskiy, M. Cowley, N. Blair, C. Sue (St Leonards, Australia)

    Objective: To clarify the genetic cause of autosomal recessive early-onset Parkinson’s Disease (EOPD) for which only a single heterozygous coding mutation could be identified. Background:…
  • 2019 International Congress

    Longitudinal DNA methylation changes, in blood, associated with Parkinson’s disease progression

    A. Henderson, K. Fisch, J. Hua, E. Driver-Dunckley, C. Sherzer, P. Desplats, T. Dunckley (Tempe, AZ, USA)

    Objective: To determine if whole blood DNA methylation profiles could distinguish Parkinson's disease from controls and whether any changes correlate with disease progression. Background: Parkinson’s…
  • 2019 International Congress

    The role of LRP10 mutations in Parkinson’s Disease and Dementia with Lewy Bodies

    A. Manini, E. Monfrini, L. Straniero, M. Vizziello, G. Franco, S. Duga, A. Di Fonzo (Milan, Italy)

    Objective: To test LRP10 in a cohort of Italian patients, with a clinical diagnosis of either Parkinson’s Disease (PD) (n=316) or Dementia with Lewy Bodies…
  • 2019 International Congress

    Expression profiles from CD14+ monocytes in PD patients with GBA mutations

    G. Riboldi, E. Udine, E. Navarro, M. Parks, B. Henderson, K. Sharma, T. Sikder, M. Zhuang, J. Crary, S. Frucht, T. Raj (New York, NY, USA)

    Objective: To study the pathogenic mechanisms associated with mutations of the GBAgenes in Parkinson’s disease (PD). Background: Mutation of GBA(encoding for glucocerebrosidase, GCase) is one of…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley